Genetic Variant Reinterpretation: Economic and Population Health Management Challenges

Phillips KA , Deverka PA , Hooker GW , Douglas MP . Genetic test availability and spending: where are we now? Where are we going?. Health aff (Millwood), 2018; 37:710–716.

Lister Hill National Center for Biomedical Communications . What is the cost of genetic testing, and how long does it take to get the results? 2020. https://ghr.nlm.nih.gov/primer/testing/costresults Accessed September 1, 2020 .

Market Watch. $22 Billion by 2024 Genetic Testing Market set for massive growth. 2019. https://www.marketwatch.com/press-release/22-billion-by-2024-genetic-testing-market-set-for-massive-growth-2019-04-03 Accessed December 8, 2019 .

Wenger AM , Harendra G , Bernstein JA , Bejerano G . Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers. Genet Med, 2017; 19:209–214.

Panos LTS , V; Dolinsky JS ; Panchani, K; LaDuca H. Variant of unknown significance rates vary by ethnicity and genes analyzed. Paper presented at American Society of Human Genetics, Maryland, 2015.

Carter NJ , Hiraki S , Yackowski L , et al. Yield of pathogenic/likely pathogenic variants in breast cancer patients undergoing an inherited cancer panel based upon ethnic background. Paper presented at American College of Medical Genetics and Genomics (ACMG), Tampa, FL, 2016.

Mauskopf JA , Sullivan SD , Annemans L , et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices—budget impact analysis. Value Health, 2007; 10:336–347.

Manchanda R , Patel S , Gordeev VS , et al. Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. J Natl Cancer Inst, 2018; 110:714–725.

Health IT Analytics . Healthy Nevada study combines genomics , population health. 2018. https://healthitanalytics.com/news/healthy-nevada-study-combines-genomics-population-health. Accessed December 8, 2019 .

Caswell-Jin JL , Gupta T , Hall E , et al. Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genet Med, 2018; 20:234–239.

Kurian AW , Li Y , Hamilton AS , et al. Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol, 2017; 35:2232–2239.